BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2475625)

  • 1. Analysis of the androgen binding in human benign prostatic hypertrophy.
    Nijs M; Coune A
    J Recept Res; 1989; 9(3):271-95. PubMed ID: 2475625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of [3H] methyltrienolone (R 1881) in rat prostate and human benign prostatic hypertrophy (BPH).
    Asselin J; Labrie F; Gourdeau Y; Bonne C; Raynaud JP
    Steroids; 1976 Oct; 28(4):449-59. PubMed ID: 64005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor proteins for androgens in prostatic disease.
    Ghanadian R; Auf G; Chisholm GD; O'Donoghue EP
    Br J Urol; 1978 Dec; 50(7):567-9. PubMed ID: 88985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of androgen receptors in human benign prostatic hypertrophy with two synthetic radiolabeled ligands.
    Schwemmer B; Böttger I; Schiessl J; Reidel G; Schütz W
    Urol Int; 1986; 41(2):133-8. PubMed ID: 2425471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the cytosol androgen receptor of the human prostate.
    Wilbert DM; Griffin JE; Wilson JD
    J Clin Endocrinol Metab; 1983 Jan; 56(1):113-20. PubMed ID: 6183286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of natural and synthetic ligands for determining androgen receptors in prostatic tumors and prostatic nodular hyperplasia].
    Kushlinskiĭ NR; Bassalyk LS; Degtiar' VG
    Med Radiol (Mosk); 1983 Aug; 28(8):13-6. PubMed ID: 6193390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative binding specificity of methyltrienolone in human and rat prostate.
    Dubé JY; Chapdelaine P; Tremblay RR; Bonne C; Raynaud JP
    Horm Res; 1976; 7(6):341-7. PubMed ID: 69599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assay of androgen binding sites by exchange with methyltrienolone (R 1881).
    Bonne C; Raynaud JP
    Steroids; 1976 Apr; 27(4):497-507. PubMed ID: 58452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor content of normal and hyperplastic human prostate.
    Trachtenberg J; Bujnovszky P; Walsh PC
    J Clin Endocrinol Metab; 1982 Jan; 54(1):17-21. PubMed ID: 6172440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific binding of [3H]-methyltrienolone to both progestin and androgen binding components in human benign prostatic hypertrophy (BPH).
    Asselin J; Mélançon R; Gourdeau Y; Labrie F; Bonne C; Raynaud JP
    J Steroid Biochem; 1979 May; 10(5):483-6. PubMed ID: 88546
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of the low affinity high capacity estrogenic binding in human benign prostatic hypertrophy.
    Nijs M; Brassinne C; Coune A
    Cancer Biochem Biophys; 1993 Jun; 13(3):195-208. PubMed ID: 7509256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptor binding characteristics in the cytosol of the rat dorsolateral prostate gland and the Dunning R-3327 prostatic adenocarcinoma.
    Rowley DR; Thompson SA; Lubaroff DM; Heidger PM
    Prostate; 1984; 5(1):101-11. PubMed ID: 6607463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of dihydrotestosterone, R 1881 and R 5020 in cytosols from normal, benign hypertrophic and cancerous human prostates.
    Nozumi K; Sato R; Ito H; Maruoka M; Shimazaki J
    Urol Int; 1981; 36(2):79-87. PubMed ID: 6169181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicochemical characterization of the androgen receptor from hyperplastic human prostate.
    Murthy LR; Chang CH; Rowley DR; Scardino PT; Tindall DJ
    Prostate; 1984; 5(6):567-79. PubMed ID: 6208540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of methyltrienolone to various androgen-dependent and androgen-responsive tissues in four animal species.
    Dubé JY; Tremblay RR; Chapdelaine P
    Horm Res; 1976; 7(6):333-40. PubMed ID: 1028725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hybrid ligand method for androgen receptor measurement.
    Stebbings WS; Anderson E; Puddefoot JR; Farthing MJ; Vinson GP
    J Steroid Biochem; 1988 Aug; 31(2):181-6. PubMed ID: 2457134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the binding of a potent synthetic androgen, methyltrienolone, to human tissues.
    Menon M; Tananis CE; Hicks LL; Hawkins EF; McLoughlin MG; Walsh PC
    J Clin Invest; 1978 Jan; 61(1):150-62. PubMed ID: 73547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of androgen receptor in cytosols from normal, benign hypertrophic and cancerous human prostates.
    Shimazaki J; Hikage T; Sato R; Kodama T; Ito H
    Endocrinol Jpn; 1981 Dec; 28(6):725-34. PubMed ID: 6179768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of ketoconazole related imidazole drugs and antiandrogens on [3H] R 1881 binding to the prostatic androgen receptor and [3H]5 alpha-dihydrotestosterone and [3H]cortisol binding to plasma proteins.
    Ayub M; Levell MJ
    J Steroid Biochem; 1989 Aug; 33(2):251-5. PubMed ID: 2788775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding to R 1881 (methyltrienolone) of proteins from human benign prostatic hypertrophy.
    Kodama T; Hasebe C; Shimazaki J
    Endocrinol Jpn; 1980 Apr; 27(2):229-37. PubMed ID: 6157523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.